J&J Leverages AI and Robots to Target $100 Billion in Annual Revenue

The launch of artificial intelligence-powered imaging and mapping capabilities for electrophysiology, early momentum for a drug releasing system for bladder cancer treatment, and progress toward a table-integrated robotic surgical system are among the latest innovations from pharmaceuticals and MedTech company Johnson & Johnson . Johnson & Johnson Chairman and CEO Joaquin Duato highlighted these products Wednesday (July 15) during the company’s second-quarter earnings call .